MedPath

Clusterheadache Implantation and Neurostimulation Technology and Health Assessment

Recruiting
Conditions
cluster headacheclusterhoofdpijnsphenopalatinestimulatorneurostimulator
Registration Number
NL-OMON21021
Lead Sponsor
Stichting VU-VU Medisch CentrumDe Boelelaan 11171081 HV Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

18-65 years old.

-classified with chronic cluster headache ICHD-3 criteria 3.1.2

Exclusion Criteria

-Patient had a change in type or dosage of preventive headache medications within one month of enrollment.

-Women of childbearing age who were pregnant, nursing, or not using contraception.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the therapeutic effect of the ATI NeurostimulationSystem in patients with drug-resistant chronic cluster headaches in the Netherlands
Secondary Outcome Measures
NameTimeMethod
To demonstrate changes in quality of life in patients treated with the ATI NeurostimulationSystem <br /><br>To demonstrate a reduction in acute and preventative pharmacological treatment in patients treated with the ATI NeurostimulationSystem <br /><br>To determine the cost-effectiveness of implementation of the ATI NeurostimulationSystem per chronic cluster headache patient<br>
© Copyright 2025. All Rights Reserved by MedPath